Skip to main content
SpringerLink
Log in
Book cover

The Yokohama System for Reporting Endometrial Cytology pp 225–233Cite as

Future Challenges and Perspectives of Endometrial Cytology

  • Chapter
  • First Online:

  • 458 Accesses

Abstract

The present chapter deals with the current states and future perspectives of digital cytology and the morphometric approach to endometrial cytology interpretation. Appropriate technological progress in these areas will significantly improve the future utility of endometrial cytology. Subsequently, we will discuss the current state of flow cytometry (LC-1000)-assisted endometrial cytology interpretation. This topic is rarely discussed elsewhere in this book. Finally, we will discuss the latest advances in the value of cell-free DNA samples in the follow-up of endometrial malignancies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Washiya K, Nakamura M, Mizuki Y, et al. Discriminating analysis of atypical squamous cells of undetermined significance of the uterine cervix using nuclear three-dimensional analysis. Acta Cytol. 2014;58:96–102.

    Article  CAS  Google Scholar 

  2. Yoshioka H, Herai A, Oikawa S, et al. Fractal analysis method for the complexity of cell cluster staining on breast FNAB. Acta Cytol. 2021;65:1–12.

    Google Scholar 

  3. FIGO committee on gynecologic oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105:103–4.

    Article  Google Scholar 

  4. Scholten AN, Smit VT, Beerman H, et al. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer. 2004;100:764–72.

    Article  Google Scholar 

  5. Lax SF, Kurman RJ, Pizer ES, et al. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol. 2000;24:1201–8.

    Article  CAS  Google Scholar 

  6. Sagae S, Saito T, Satoh M, et al. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading. Oncology. 2004;67:344–50.

    Article  Google Scholar 

  7. Nishimura Y, Watanabe J, Jobo T, et al. Cytologic scoring of endometrioid adenocarcinoma of the endometrium. Cancer. 2005;105:8–12.

    Article  Google Scholar 

  8. Yamaguchi T, Kawahara A, Hattori S, et al. Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer. Cytopathology. 2015;26:157–66.

    Article  CAS  Google Scholar 

  9. Kato R, Hasegawa K, Torii Y, et al. Cytological scoring and prognosis of poorly differentiated endometrioid adenocarcinoma. Acta Cytol. 2015;59:83–90.

    Article  CAS  Google Scholar 

  10. Norimatsu Y, Irino S, Maeda Y, et al. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: a prospective approach to combined evaluation in endometrial neoplasms and look alikes. Cytopathology. 2021;32:65–74.

    Article  Google Scholar 

  11. Pouliakis A, Margari C, Margari N, et al. Using classification and regression trees, liquid-based cytology and nuclear morphometry for the discrimination of endometrial lesions. Diagn Cytopathol. 2014;42:582–91.

    Article  Google Scholar 

  12. Baak JP. Further evaluation of the practical applicability of nuclear morphometry for the prediction of the outcome of atypical endometrial hyperplasia. Anal Quant Cytol Histol. 1986;8:46–8.

    CAS  PubMed  Google Scholar 

  13. Nakamura M, Ueda M, Iwata T, et al. A clinical trial to Verify the efficiency of the LC-1000 exfoliative cell analyzer as a new method of cervical cancer screening. Acta Cytol. 2019;63:391–400.

    Google Scholar 

  14. Heo I, Kwak HJ, Nah EH, et al. Evaluation of the LC-1000 flow cytometry screening system for cervical Cancer screening in routine health checkups. Acta Cytol. 2018;62:279–87.

    Article  CAS  Google Scholar 

  15. Rolfo C, Mack PC, Scagliotti GV, et al. Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC. J Thrac Oncol. 2018;13:1248–68.

    Article  Google Scholar 

  16. Piietrasz D, Pecuchet N, Garlan F, et al. Plasma circulating tumor DNA in pancreatic cancer is a prognostic marker. Clin Cancer Res. 2017;23:116–23.

    Article  Google Scholar 

  17. Strickler JH, Loree JM, Ahronian LG, et al. Genomic landscape of cell-free DNA in patients with colorectal cancer. Cancer Discov. 2018;8:164–73.

    Article  CAS  Google Scholar 

  18. Kwapisz D. The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? Ann Transl Med. 2017;5:46. https://doi.org/10.21037/atm.01.32.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu X, Lu Y, Zhu G, et al. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patient with advanced non-small cell lung cancer: comparison of methodologies. J Clin Pathol. 2013;66:1065–9.

    Article  Google Scholar 

  20. Kawahara A, Fukumitsu C, Azuma K, et al. A combined test using both cell sediments and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients. Cytopathology. 2018;29:150–5. https://doi.org/10.1111/cyt.12517.

  21. Cheng X, Zhang L, Chen Y, et al. Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer. J Ovarian Res. 2017;10:75. https://doi.org/10.1186/s13048-017-0369-5.

  22. Muinelo-Romay L, Casas-Arozamena AM. Liquid biopsy in endometrial cancer: new opportunities for personalized oncology. Int J Mol Sci. 2018;19:2311. https://doi.org/10.3390/ijms19082311.

    Article  CAS  PubMed Central  Google Scholar 

  23. Chen Q, Zhhang Z-H, Wang S, et al. Circulating cell-free DNA or circulating tumor DNA in the management of ovarian and endometrial cancer. Onco Targets Therapy. 2019;12:11517–30.

    Article  CAS  Google Scholar 

  24. Cicchillitti L, Corrado G, De Angeli M, et al. Circulating cell-free DNA content as blood based biomarker in endometrial cancer. Oncotarget. 2017;8:115230–43.

    Article  Google Scholar 

  25. Dobrzycka B, Terlikowski SJ, Mazurek A. Et a. circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer. Int J Cancer. 2010;127:612–21.

    Article  CAS  Google Scholar 

  26. Vizza E, Corrado G, De Angeli M, et al. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer. J Exp Clin Res. 2018;37:16. https://doi.org/10.1186/s13046-018-0688-4.

  27. Casslen B, Kobayashi TK, Stormby N. Cyclic variation of the cellular components in human uterine fluid. J Reprod Fertil. 1982;66:213–8.

    Google Scholar 

  28. Ponti G, Manfredini M, Tomasi A. Non-blood source of cell-free DNA for cancer molecular profiling in clinical pathology and oncology. Crit Rev Oncol Hematol. 2019;141:36–42. https://doi.org/10.1016/jcritrevone.2019.06.005.

  29. Papanicolaou GN, Traut HF. Diagnosis of uterine cancer by the vaginal smear. New York: The Commonwealth Fund; 1943.

    Google Scholar 

  30. Carmichael DE. Diagnosis by vaginal smear. In: The Pap Smear: Life of George N. Papanicolaou. Illinois: Charles C Thomas Publisher; 1973. p. 54–61.

    Google Scholar 

  31. Kinde I, Bettegowda C, Wang Y, et al. Evaluation of DNA from the Papanicolaou Test to detect ovarian and endometrial cancers. Sci Transl Med. 2013;5:167ra4. https://doi.org/10.1126/scitranslmed.3004952.

  32. Wang Y, Li L, Douville D, et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med. 2018;10:eaap8793. https://doi.org/10.1126/scitranslmed.aap8793.

  33. Matsuura M, Yamaguchi K, Tamate M, et al. Efficacy of liquid-based genetic diagnosis of endometrial cancer. Cancer Sci. 2018;109:4025–32.

    Article  CAS  Google Scholar 

  34. Nair N, Camacho-Vanegas RD, et al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study. PLoS Med. 2016;13:e1002206. https://doi.org/10.1371/journal.pmed.1002206.

  35. Maritschnegg E, Wang Y, Pecha N, et al. Lavage of the uterine cavity for molecular detection of Mullerian duct carcinomas: a proof-of-concept study. J Clin Oncol. 2015;33:4293–300.

    Article  Google Scholar 

  36. Casas-Arozamena DE, Moiola CP, et al. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer. J Clin Med. 2020;9:585. https://doi.org/10.3390/jcm9020585.

    Article  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Dokkyo Medical University, Tochigi, Japan

    Yasuo Hirai

  2. PCL Japan Pathology and Cytology Center, PCL Inc., Saitama, Japan

    Yasuo Hirai

  3. Division of Health Sciences, Cancer Education and Research Center, Osaka University Graduate School of Medicine, Osaka, Japan

    Tadao K. Kobayashi

  4. Department of Medical Technology, Faculty of Health Sciences, Ehime Prefectural University of Health Sciences, Tobe-cho, Iyo-gun, Ehime, Japan

    Yoshiaki Norimatsu

  5. Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Science, Hirosaki, Japan

    Jun Watanabe

  6. Department of Gynecology and Obstetrics, Faculty of Medical Sciences, University of Fukui, Fukui, Japan

    Tetsuji Kurokawa & Akiko Shinagawa

  7. Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan

    Akira Mitsuhashi

  8. Department of Diagnostic Cytopathology, Kurume University Hospital, Fukuoka, Japan

    Akihiko Kawahara

Authors
  1. Yasuo Hirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadao K. Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiaki Norimatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsuji Kurokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akiko Shinagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Akira Mitsuhashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Akihiko Kawahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuo Hirai .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Dokkyo Medical University, Tochigi, Japan

    Yasuo Hirai

  2. Clinical Cytology Service, Istituto Cantonale dì Patologia, Ente Ospedaliero Cantonale, Locarno, Switzerland

    Franco Fulciniti

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hirai, Y. et al. (2022). Future Challenges and Perspectives of Endometrial Cytology. In: Hirai, Y., Fulciniti, F. (eds) The Yokohama System for Reporting Endometrial Cytology. Springer, Singapore. https://doi.org/10.1007/978-981-16-5011-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-5011-6_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-5010-9

  • Online ISBN: 978-981-16-5011-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation